Invion Ltd has released a press release.
Pause in Trading
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Invion
- Hanlim & Korean Government Fund Pathway to Clinical Trial
- Invion Secures Expanded Photosoft Global Exclusive License
- Appendix 4C and Quarterly Activities Report - September 2025
- Funded Collaboration Agreement with Protect Animal Health
- Repayment of Lind Facility with Successful Capital Raise
Later from Invion
- Trading Halt
- Major Shareholders Lead Invion $1.3M Capital Raise
- Appendix 4C and Quarterly Activities Report - December 2025
- Appendix 4D and Half Year Financial Report
- Skin Cancer Trial Moves to BCC With More Encouraging Signals
Follow Invion into a list and get an email when it puts out news.
Follow Invion